key: cord-0814482-aisazvrc authors: Yousif, M.; Hong, H.; Malfeld, S.; Smit, S.; Makhathin, L.; Motsamai, T.; Tselana, D.; Manamela, M.; Kamupira, M.; Maseti, E.; Otwombe, K.; McCarthy, K.; Suchard, M. title: Measles incidence in South Africa: a six-year review, 2015 - 2020 date: 2022-02-05 journal: nan DOI: 10.1101/2022.02.03.22270382 sha: 303747e66f05114cc0ee5e2579cb1de59c1c9ace doc_id: 814482 cord_uid: aisazvrc In 2012 the World Health Organization (WHO) aimed to eliminate measles in five regions by 2020. This retrospective descriptive study reviewed measles surveillance data in South Africa for the period 2015 - 2020 to document the epidemiology of measles and the progress made towards meeting the 2020 measles elimination goal. A total of 22,578 specimens were tested over the period 2015 - 2020 yielding 401 (1.8%) confirmed measles cases, 321 (1.4%) compatible and 21,856 (96.8%) discarded cases. The most affected age group was 0-4 year olds. At the provincial level, South Africa achieved adequate surveillance, defined as more than two cases of febrile rash notified annually per 100 000 popoulation, except for KwaZulu-Natal and Limpopo in 2020, probably due to COVID-19 lockdown restrictions. Of confirmed cases, only 26% were vaccinated, 3% were too young to receive vaccines, 5% were not vaccinated, and 65% had vaccination status unknown. Measles vaccine effectiveness amongst 1-4 year olds was 80%. Using the standard case definition, South Africa achieved the measles elimination target of less than one case per one million nationally in years 2015, 2016 and 2020. The years 2017 to 2019 had incidence rates exceeded one per million nationally. Using a narrow case definition, that excluded positive rubella cases, improved the indicators with only the year 2017 having an incidence rate of more than one per million. South Africa displays intermittent measles outbreaks approximately six-yearly interspersed by inter-epidemic periods in which the country meets measles elimination targets. Intense effort is needed to increase the vaccine coverage to avoid periodic outbreaks. Enhanced molecular testing of each case will be required as measles incidence declines regionally. programme was expanded, a second dose was added at 18 months. In 2016, the schedule changed to 79 earlier administration at 6 and 12 months of age (10 As part of febrile rash surveillance, any suspected case of measles seen by a clinician should be notified 90 within 24 hours and a blood specimen should be collected and sent to the National Institute for 91 Communicable Diseases (NICD) for testing. Febrile rash cases thus comprise multiple aetiologies, the 92 common of which in the South African setting is rubella. In this manuscript we review the febrile 93 surveillance data for the period 2015 to 2020, to document the epidemiology of measles in South Africa, 94 and the progress made towards national measles elimination. Rubella incidence has been previously 95 reported (Hong et al, submitted) 96 Methods the period 2015-2020 to document the epidemiology of measles and the progress made towards 100 meeting the 2020 measles elimination goal. Ethical approval was obtained from the Human Research . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 5, 2022. ; https://doi.org/10.1101 https://doi.org/10. /2022 IgM. Figure 1 shows the trend of confirmed measles cases over the six years (2015 -2020). Measles cases 166 ranged from 0 to 14 per month, with exception of 2017, in which confirmed cases ranged from 3 to 28 per 167 month, corresponding with an outbreak ( Figure 1A) . After excluding rubella positive cases, measles cases 168 ranged from 0 to 7 per month except in 2017 ( Figure 1B) . Measles cases occurred mostly in the age group . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 5, 2022. ; https://doi.org/10.1101/2022.02.03.22270382 doi: medRxiv preprint of 0-4 years (n=148, 37.0%), and 20-44 years (n=105, 26.2%) (Figure 2 ). The age-standardized incidence 170 rates showed that the group 0-4 years had the highest incidence rates ( Table 1) . The sex distribution 171 among the age groups did not show any significant pattern. 172 Figure 1 caption: Monthly incidence of measles infection in South Africa during 2015-2020. Figure 1A 173 shows confirmed measles cases including rubella positive cases. Figure 1B shows confirmed measles cases 174 excluding rubella cases. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 5, 2022. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 5, 2022. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 5, 2022. ; 12 189 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 5, 2022. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 5, 2022. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 5, 2022. In this review, we aimed to evaluate the level of South Africa's readiness to eliminate measles. We 250 reviewed six years' retrospective data from the national surveillance programme for febrile rash illness. Between the years 2015 to 2020, a total of 285 confirmed measles cases (excluding rubella infections) 252 were detected in South Africa, with the highest incidence rate of 6.1 cases per million detected in 2017 in 253 Gauteng province, while the lowest incidence rate of infection was zero detected in many provinces in 254 multiple years ( Table 2) . Younger children aged from 0-4 years were the most affected age group. Stratified by population figures, 256 the highest incidence rate was in the age group of 0-4 years at 7.8 per million in 2017, 3.0 per million in adult cases, due to the outbreak that affected the country ( Table 1) . In 2017, one death was reported 259 (ref?) but outcome data for most cases was not available. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 5, 2022. ; https://doi.org/10.1101 https://doi.org/10. /2022 In the past six years, South Africa had a good surveillance system in place, evidenced by the adequate 261 non-measles rash surveillance rate of more than 2.0 per 100,000 population in all provinces from 2015 to 262 2020, except in 2020 in KwaZulu-Natal and Limpopo, which had a rate of 1.4 and 1.0 per 100,000 263 respectively. This reduction of the rate of non-measles rash surveillance was probably due to the 264 lockdown from March to August imposed because of the COVID-19 pandemic, resulting in reduced health-265 seeking behavior but also lowering the transmission of respiratory-borne viruses. The non-measles rash 266 surveillance in South Africa in 2020 was 2.1 per 100,000, still above the recommended threshold. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 5, 2022. Using the narrow case definition, which excluded the rubella positive cases, measles vaccine effectiveness 300 in South Africa was determined as 80% among children aged between 1-4 years old. This is low compared showed that the odds of being vaccinated and having measles was hifher prior to 2016, when children 303 received vaccine at 9 months and 18 months, compared to post 2016 when children receive the vaccine 304 at 6 months and 12 months. Early vaccination might blunt the immune response to subsequent measles 305 vaccine doses (24). Ongoing evaluation of vaccine effectiveness with the new schedule is warranted. A . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted February 5, 2022. ; https://doi.org/10.1101/2022.02.03.22270382 doi: medRxiv preprint 306 confounder of these results may be that the measles cases in our dataset occurred mostly during the 2017 307 outbreaks, resulting in most measles cases in our dataset occurring after 2017. Our work is also limited by 308 missing information in our programmatic data, particularly the number of respondents with available 309 information on measles vaccination status and of doses. Nevertheless, our program data provides a good 310 reflection of the impact of the vaccine program in a routine setting. In conclusion, the results of this study suggested that more effort is needed to increase the vaccine 312 coverage in the country as well as the completion of indicators including clinical investigation form, unique 313 EPID number and information on vaccination status in febrile rash cases. Improvements in laboratory 314 confirmatory measles diagnostic assays will also be required to meet the goals for measles elimination. Moreover, catch-up vaccinations will be needed to fill the gaps particularly following the COVID-19 316 pandemic in which many children missed their routine immunizations. There was no specific research funding for this study. Morbilliviruses and human disease Dermatological Signs and Symptoms of Measles: A Prospective Case 338 Series and Comparison with the Literature Measles and Rubella Global Strategic Plan 2012-2020 Midterm Review Joint News Release:More than 140,000 die from measles as cases surge worldwide 351 Status of measles 358 rubella surveillance review Measles 361 outbreak in South Africa South Africa: epidemiology of laboratory-confirmed measles cases and assessment of 364 intervention Annual measles, rubella and congenital rubella survellance review, South Africa Experts caution against stagnation of immunization coverage in Africa Use of whole blood dried on 374 filter paper for detection and genotyping of measles virus Challenges of 376 measles and rubella laboratory diagnostic in the era of elimination Uneven routine immunization coverage threatens the health of South Africa's youngest 384 children Evaluation of Diagnostic 387 Accuracy of Eight Commercial Assays for the Detection of Measles Virus-Specific IgM Antibodies Simultaneous IgM reactivity by 390 EIA against more than one virus in measles, parvovirus B19 and rubella infection Vaccines for measles, mumps and rubella in 393 children. Evidence-Based Child Heal A Vaccines for measles, mumps, 395 rubella, and varicella in children Effect 397 of measles vaccination in infants younger than 9 months on the immune response to subsequent 398 measles vaccine doses: a systematic review and meta-analysis 331 We acknowledge the support and contribution by the provincial expanded programme on Immunisation 332 coordinators, and the provincial communicable disease control teams, notifiable medical conditions